Covered recipient · General Payments record
MEGAN R NASH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,622.84
- Reported across 97 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $591.98 | 33 |
| Education | $64.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $177.89 | 13 |
| Astellas Pharma US Inc | $148.49 | 5 |
| Novo Nordisk AS | $120.45 | 6 |
| GlaxoSmithKline, LLC. | $106.31 | 5 |
| PFIZER INC. | $41.40 | 2 |
| Lilly USA, LLC | $32.24 | 2 |
| Inspire Medical Systems, Inc. | $30.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.25 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101701 | CMS |
| ABBVIE INC. | $12.45 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101703 | CMS |
| ABBVIE INC. | $2.88 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101705 | CMS |
| ABBVIE INC. | $19.01 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101707 | CMS |
| ABBVIE INC. | $13.41 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101709 | CMS |
| ABBVIE INC. | $24.37 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101711 | CMS |
| ABBVIE INC. | $8.65 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101713 | CMS |
| ABBVIE INC. | $7.45 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101715 | CMS |
| ABBVIE INC. | $10.29 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101717 | CMS |
| ABBVIE INC. | $16.14 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101719 | CMS |
| ABBVIE INC. | $18.19 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101721 | CMS |
| ABBVIE INC. | $5.76 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101723 | CMS |
| ABBVIE INC. | $18.04 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105101725 | CMS |
| Astellas Pharma US Inc | $23.68 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139289882 | CMS |
| Astellas Pharma US Inc | $64.99 | 01/17/2024 | Education | Undisputed | 01/23/2026 | 1139388356 | CMS |
| Astellas Pharma US Inc | $17.14 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139315754 | CMS |
| Astellas Pharma US Inc | $16.22 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139329066 | CMS |
| Astellas Pharma US Inc | $26.46 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139421359 | CMS |
| GlaxoSmithKline, LLC. | $20.55 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116097636 | CMS |
| GlaxoSmithKline, LLC. | $23.29 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116234367 | CMS |
| GlaxoSmithKline, LLC. | $23.52 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116442393 | CMS |
| GlaxoSmithKline, LLC. | $22.30 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116336629 | CMS |
| GlaxoSmithKline, LLC. | $16.65 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116293815 | CMS |
| Inspire Medical Systems, Inc. | $30.19 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148087439 | CMS |
| Lilly USA, LLC | $15.97 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135188129 | CMS |
| Lilly USA, LLC | $16.27 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135186963 | CMS |
| Novo Nordisk Inc | $23.37 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096895095 | CMS |
| Novo Nordisk Inc | $17.93 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096636446 | CMS |
| Novo Nordisk Inc | $19.54 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097356040 | CMS |
| Novo Nordisk Inc | $21.14 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097386322 | CMS |
| Novo Nordisk Inc | $18.61 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097361615 | CMS |
| Novo Nordisk Inc | $19.86 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097829361 | CMS |
| PFIZER INC. | $21.34 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131247061 | CMS |
| PFIZER INC. | $20.06 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131440777 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.